Empirical oral antibiotic therapy for low risk febrile cancer patients with neutropenia

Cancer Investigation

Volumn 20, Issue 3, 2002, Pages 420-433

  Koh, Andrew ^a   Pizzo, Philip A ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; ANTIBIOTIC AGENT; CARBENICILLIN; CEFTAZIDIME; CIPROFLOXACIN; CLINDAMYCIN; GATIFLOXACIN; LEVOFLOXACIN; OFLOXACIN; PEFLOXACIN; PENICILLIN G; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ACUTE KIDNEY FAILURE; AMBULATORY CARE; ANTIBIOTIC THERAPY; ARTICLE; CANCER PATIENT; CAREGIVER; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; DIARRHEA; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE SEVERITY; FATALITY; FEBRILE NEUTROPENIA; FEVER; GASTROINTESTINAL TOXICITY; HOME CARE; HOSPITAL INFECTION; HOSPITAL PATIENT; HUMAN; INFECTION; INFECTION PREVENTION; INFECTION RISK; MAJOR CLINICAL STUDY; NEPHROTOXICITY; NEUTROPENIA; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY OF LIFE; RISK ASSESSMENT; RISK MANAGEMENT; SAFETY;

ADMINISTRATION, ORAL; AMBULATORY CARE; ANTI-BACTERIAL AGENTS; ANTINEOPLASTIC AGENTS; COST CONTROL; CROSS INFECTION; FEVER; HUMANS; INFUSIONS, INTRAVENOUS; NEOPLASMS; NEUTROPENIA; PRACTICE GUIDELINES; QUALITY OF LIFE; RISK FACTORS;

EID: 0036247164     PISSN: 07357907     EISSN: None     Source Type: Journal    
DOI: 10.1081/CNV-120001186     Document Type: Article

References (40)

1. Three antibiotic regimens in the treatment of infection in febrile granulocytopenic patients with cancer
2. Ceftazidime combined with a short or long course of amikacin for empirical therapy of gram-negative bacteremia in cancer patients with granulocytopenia
3. Efficacy and toxicity of single daily doses of amikacin and ceftriaxone versus multiple daily doses of amikacin and ceftazidime for infection in patients with cancer and granulocytopenia
4. 1997 Guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever
5. Gram-positive bacteraemia in granulocytopenic cancer patients
6. A comparison of outcome from febrile neutropenic episodes in children compared with adults: Results from four EORTC studies
7. Gram-positive infections and the use of vancomycin in 550 episodes of fever and neutropenia
8. Alpha-streptococcal septicemia in leukemic children treated with continuous or large dosage intermittent cytosine arabinoside
9. Cytosine arabinoside as a major risk factor for Streptococcus viridans septicemia following bone marrow transplantation: A 5-year prospective study
10. Fever in the pediatric and young adult patient with cancer. A prospective study of 1001 episodes
11. Monotherapy for fever and neutropenia in cancer patients: A randomized comparison of ceftazidime versus imipenem
12. Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia
13. Empiric antibiotic and antifungal therapy for cancer patients with prolonged fever and granulocytopenia
14. The medical course of cancer patients with fever and neutropenia. Clinical identification of a low-risk subgroup at presentation
15. Risk assessment in cancer patients with fever and neutropenia: A prospective, two-center validation of a prediction rule
16. The outpatient management of febrile neutropenia in cancer patients
17. Predicting the risk of bacteremia in childen with fever and neutropenia
18. Low-risk prediction rule for pediatric oncology patients presenting with fever and neutropenia
19. Early discharge of low-risk febrile neutropenic children and adolescents with cancer
20. Safety and cost effectiveness of early hospital discharge of lower risk children with cancer admitted for fever and neutropenia
21. Home antibiotic therapy for low-risk cancer patients with fever and neutropenia: A pilot study of 30 patients based on a validated prediction rule
22. Outpatient treatment of febrile neutropenic patients with cancer
23. The sanford guide to antimicrobial therapy
24. Vancomycin added to empirical combination antibiotic therapy for fever in granulocytopenic cancer patients
25. Home treatment of febrile neutropenia: An empirical oral antibiotic regimen
26. Randomised comparison of oral ofloxacin alone with combination of parenteral antibiotics in neutropenic febrile patients
27. Self-administered antibiotic therapy for chemotherapy-induced, low-risk febrile neutropenia in patients with nonhematologic neoplasms
28. Feasibility of outpatient management of fever in cancer patients with low-risk neutropenia: Results of a prospective randomized trial
29. Outpatient treatment of neutropenic fever with oral antibiotics and granulocyte colony-stimulating factor
30. Outpatient therapy with oral ofloxacin for patients with low risk neutropenia and fever: A prospective, randomized clinical trial
31. Outpatient treatment of febrile episodes in low-risk neutropenic patients with cancer
32. Acute renal failure due to ciprofloxacin
33. Acute renal failure secondary to oral ciprofloxacin therapy: A presentation of three cases and a review of the literature
34. Allergic nephropathy associated with ciprofloxacin
35. Randomized trial comparing oral ciprofloxacin plus penicillin V with amikacin plus carbenicillin or ceftazidime for empirical treatment of febrile neutropenic cancer patients
36. Oral versus intravenous empirical antimicrobial therapy for fever in patients with granulocytopenia who are receiving cancer chemotherapy
37. A double-blind comparison of empirical oral and intravenous antibiotic therapy for low-risk febrile patients with neutropenia during cancer chemotherapy
38. Outpatient treatment of fever and neutropenia for low risk pediatric cancer patients
39. Economic and resource utilization analysis of outpatient management of fever and neutropenia in low-risk pediatric patients with cancer
40. Fever and neutropenia-how to use a new treatment strategy